2021 American Transplant Congress

TOPIC: Clinical Science

Serum Phosphatidylethanol is Superior to Urine Ethyl Glucuronide for Diagnosis of Alcohol Relapse in Liver Transplant Recipients
N. Lim¹, T. Leventhal¹, M. Thomson¹, M. Hassan¹, J. Thompson¹, S. Chinnakotla², V. Kirchner², T. Pruett², R. Kandaswamy², V. Humphreville², A. Adams², J. Lake¹
Severe Hypoxemia After Liver Transplantation in the Hepatopulmonary Syndrome
J. Doi, M. Fujiki, G. DAmico, K. Sasaki, T. Diago, F. Aucejo, C. Kwon, B. Eghtesad, K. Hashimoto, C. Miller, Q. Cristiano
Sharing Under KAS – What is the Impact According to KDPI?
M. Jacobs, R. Stratta, C. Jay
Sharp Anti-HLA Antibody Development Due to Concomitant Graft Nephrectomy and Immunosuppression Withdrawal After Early Graft Loss
R. Valero¹, A. Aguilera¹, E. Rodrigo¹, D. San Segundo², M. Lopez-Hoyos², J. Ruiz¹
Short Term Outcomes in Previously Covid Positive Kidney Transplant Recipients in Pre-vaccine Era
R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel
Short Term Outcomes in Previously Covid Positive Living Kidney Donors and Their Recipients
R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel
Short Waiting Time is Not Associated with Decrease in Disease-free Survival in Liver Transplant Recipients with HCC
J. Daum¹, N. Gupta¹, B. Aqel², L. Mi³, J. Harbell⁴
Should We Curtail the Importance of Non-modifiable Risk Factors in Dcd Liver Risk Stratification?
R. Meier¹, Y. Kelly², S. Yamaguchi², H. Braun², T. Lunow-Luke², D. Adelmann², C. Niemann², D. Maluf¹, Z. Dietch², P. Stock², S. Kang², S. Feng², A. Posselt², J. Gardner², C. Freise², R. Hirose², C. Freise², N. Ascher², J. Roberts², G. Roll²
Should We Worry About Covid-19 Infection in Pediatric SOT?
U. Ekong¹, S. Paul¹, S. Royal², J. Chahine³, N. Yazigi¹, S. Kaufman¹, K. Khan¹, C. Matsumoto¹, A. Kroemer¹, T. Fishbein¹
Significance of Detectable but Unquantifiable Viremias Post Renal Transplantation
M. Chaung, S. Puri, S. Bunin, Z. Mondal, O. Eletta, R. Pelletier, A. Bongu